Lakeshore Biopharma CO (LSBCF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 03-2025 | 03-2024 | 03-2023 | 12-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,929 | -61,094 | -21,171 | -546 | N/A |
| Depreciation Amortization | 5,106 | 5,946 | 5,339 | N/A | 0 |
| Income taxes - deferred | -601 | -3,063 | 165 | N/A | N/A |
| Accounts receivable | -8,309 | 1,960 | -24,048 | N/A | N/A |
| Accounts payable and accrued liabilities | -2,539 | -1,785 | 7,222 | N/A | N/A |
| Other Working Capital | -16,074 | -6,454 | -13,497 | -64 | 0 |
| Other Operating Activity | 19,491 | 22,879 | 19,435 | -4 | 0 |
| Operating Cash Flow | $-16,854 | $-41,611 | $-26,554 | $-613 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,652 | -6,237 | -7,668 | N/A | 0 |
| Purchase Sale Intangibles | -718 | N/A | -625 | N/A | N/A |
| Other Investing Activity | -718 | 0 | -625 | -200,000 | 0 |
| Investing Cash Flow | $-2,369 | $-6,237 | $-8,292 | $-200,000 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 46,644 | 47,618 | 36,001 | N/A | N/A |
| Common Stock Issued | N/A | 40,056 | N/A | 196,000 | N/A |
| Other Financing Activity | -47,143 | -58,744 | 10,196 | 5,498 | 0 |
| Financing Cash Flow | $-499 | $28,930 | $46,197 | $201,498 | $N/A |
| Exchange Rate Effect | 349 | 1,466 | 3,100 | N/A | 0 |
| Beginning Cash Position | 34,347 | 52,202 | 39,447 | N/A | 0 |
| End Cash Position | 14,974 | 34,750 | 53,898 | 885 | N/A |
| Net Cash Flow | $-19,373 | $-17,452 | $14,451 | $885 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,854 | -41,611 | -26,554 | -613 | N/A |
| Capital Expenditure | -1,770 | -6,237 | -7,678 | N/A | N/A |
| Free Cash Flow | -18,625 | -47,848 | -34,231 | -613 | 0 |